reviewNatureJan 15, 2013Closed access

mTOR is a key modulator of ageing and age-related disease

SCSimon C. JohnsonPSPeter S. RabinovitchMKMatt Kaeberlein

University of Washington · Seattle University · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,677
total citations
FWCI
47.47
Percentile
100%
References
100
Citations per year

Authors

3

Topics & keywords

Topics
Keywords
  • PI3K/AKT/mTOR pathway
  • Ageing
  • Psychological intervention
  • Mechanistic target of rapamycin
  • Medicine
  • Disease
  • Discovery and development of mTOR inhibitors
  • Sirolimus
No related works found for this paper.

Funding